Stay updated on Avelumab Program Rollover Study Clinical Trial
Sign up to get notified when there's something new on the Avelumab Program Rollover Study Clinical Trial page.

Latest updates to the Avelumab Program Rollover Study Clinical Trial page
- Check5 days agoChange DetectedA new revision label, v3.6.5, was added and the previous label v3.6.4 was removed. This updates the page's revision metadata but does not change the study content or functionality.SummaryDifference0.0%

- Check12 days agoNo Change Detected
- Check20 days agoChange DetectedThe page now displays revision v3.6.4, replacing v3.6.3, indicating a small update to the page's content or presentation.SummaryDifference0.0%

- Check27 days agoNo Change Detected
- Check41 days agoChange DetectedThe study record gains two new Japan cross-reference identifiers: JapicCTI-194697 and jRCT2080224625. It also updates the record with a newer revision tag (Revision: v3.6.3) and recent dates, reflecting metadata enhancements to the entry.SummaryDifference0.2%

- Check48 days agoChange DetectedRevision: v3.6.2 was added, replacing the previous v3.6.0. This represents a minor metadata update with no changes to study data or functionality.SummaryDifference0.0%

- Check62 days agoChange DetectedThe page now communicates that no participants are being enrolled for this rollover study and adds new help/navigation sections (How to Read a Study Record, Common Questions, How to Join a Study). The Intervention/Treatment heading formatting changes and the revision version are updated from v3.5.5 to v3.6.0.SummaryDifference0.2%

- Check70 days agoChange DetectedA new page revision is introduced, showing revision v3.5.5 and replacing v3.5.4. This indicates a page-level update and does not change the study details or their presentation.SummaryDifference0.0%

Stay in the know with updates to Avelumab Program Rollover Study Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Avelumab Program Rollover Study Clinical Trial page.